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Abstract  Most  patients  presenting  with  acute  chest  pain  (ACP)  at  the  emergency  unit  do
not have  any  marked  electrocardiogram  abnormalities  or  known  history  of  heart  disease.  Iden-
tifying the  few  patients  who  have,  or  will  actually  develop  acute  coronary  syndrome  in  this
group that  is  considered  to  be  at  low  risk,  is  an  actual  clinical  challenge  for  emergency  depart-
ment physicians.  In  these  patients,  the  goal  of  complementary  non-invasive  morphological  or
functional imaging  tests  is  to  exclude  heart  disease.  The  diagnostic  values  of  coronary  CT
angiography  include  a  sensitivity  of  96%  and  a  negative  likelihood  ratio  of  0.09,  which  are
highly contributory  to  the  diagnosis,  and  the  integration  of  this  imaging  test  into  a  decision
tree algorithm  appears  to  be  the  least  expensive  strategy  with  the  best  cost/effective  ratio.
Coronary CT  angiography  is  indicated  in  the  presence  of  ACP  associated  with  an  inconclusive
electrocardiogram,  in  the  absence  of  any  other  obvious  diagnoses,  when  the  ultrasensitive
troponin assay  is  negative  or  the  dynamic  changes  are  modest,  slow  and/or  inconclusive.
Ideally, coronary  CT  angiography  should  be  performed  within  3  to  48  hours  after  the  initial
consultation.
© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.∗ Corresponding author.
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tate of the art
cute  chest  pain  (ACP)  represents  30%  of  the  consulta-
ions  in  emergency  units  [1].  Approximately  5%  of  the
atients  who  present  with  this  symptom  in  the  emer-
ency  unit  will  develop  segment  elevation  (ST+)  myocardial
nfarction  (STEMI)  and  will  be  treated  by  a  coronary  reper-
usion  strategy  [2].  Another  quarter  of  these  subjects  will
rogress  to  non  ST+  Acute  Coronary  Syndrome  (ACS).  This
ncludes  non  ST+  segment  elevation  myocardial  infarction
NSTEMI),  which  is  generally  rapidly  diagnosed  and  treated
y  early  revascularization,  and  unstable  angina,  deﬁned  as
n  authentic  transitory  myocardial  ischemia  without  necro-
is,  which  is  often  more  difﬁcult  to  diagnose  [3].  Analysis
f  these  results  shows  that  most  patients  consulting  for  ACP
n  the  emergency  room  have  no  marked  changes  in  ECG  or
istory  of  heart  disease.  These  studies,  which  are  already
uite  dated  [4—6],  classiﬁed  these  patients  as  ‘‘low  risk’’
ased  on  a  short-term  STEMI  rate  of  2%,  NSTEMI  rate  of  1  to
%  and  unstable  angina  of  4%.  Thus,  the  primary  goal  of  an
mergency  physician  in  the  management  of  ACP  is  to  strat-
fy  patients  in  relation  to  their  level  of  risk  while  eliminating
CS  from  other  severe  diagnoses.  This  goal  is  usually  reached
y  using  standardized  protocols  familiar  to  specialists  [7,8].
o  identify  the  few  patients  who  actually  have  ACS  in  what  is
onsidered  a  low  risk  group  is  still  a  real  clinical  challenge  for
mergency  physicians.  They  have  therefore  developed  the
recautionary  principle  of  ‘‘Rule  Out  Myocardial  Infarction’’
in  fact  ‘‘rule  out  ACS’’)  resulting  in  a  very  low  risk  thresh-
ld,  whose  excellent  sensitivity  is  obtained  at  the  expense  of
peciﬁcity.  The  result  of  this  approach  is  that  a  large  number
f  patients  are  admitted  into  monitoring  units  for  additional
ests,  increasing  the  probability  of  false  positives  (and  all  of
he  potential  associated  iatrogenic  complications)  as  well  as
dded  expense.  Thus,  in  the  United  States,  nearly  80%  of  the
atients  consulting  for  ACP  are  kept  for  observation,  even
n  the  absence  of  any  real  change  in  ECG  or  elevated  car-
iac  enzymes.  Less  than  15%  of  these  hospitalized  patients
ave  conﬁrmed  ACS,  while  the  annual  diagnostic  cost  of
CP  in  emergency  units  is  around  12  million  dollars.  On  the
ther  hand,  although  all  existing  emergency  unit  assessment
nd  triage  strategies  tend  to  be  somewhat  overcautious,  2%
f  these  individuals  still  leave  the  hospital  too  early  with
ndiagnosed  ACS  and  a  risk  of  morbidity  and  mortality  that
s  two-fold  [9].  These  ‘‘errors’’  are  the  source  of  20%  of
he  medicolegal  complaints  for  malpractice  in  the  United
tates.
xisting practices
o  meet  this  challenge  numerous  diagnostic  strategies  are
ow  available,  including  chest  pain  centers,  the  use  of
ardiac  biochemical  markers,  new  risk  scores,  accelerated
iagnostic  protocols  and  non-invasive  imaging  of  the  heart
nd  coronary  arteries  [10,11].  Guidelines  for  the  stratiﬁca-
ion  of  risk  in  non  ST+  ACS  recommend  the  use  of  the  GRACE
core  [12].  This  includes  the  Killip  classiﬁcation  (Evalua-
ion  of  Left  Ventricular  Systolic  Dysfunction)  based  on  the
mportance  of  rales  and  crackles  during  the  clinical  work-
p,  systolic  pressure,  heart  rate,  age,  creatinine  levels,
he  presence  of  cardiac  arrest  at  admission,  ST  segment
a
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bnormalities  or  elevated  cardiac  biomarkers.  It  should  be
alculated  at  admission  as  well  as  when  the  patient  is
ischarged.  With  the  GRACE  score,  low  risk  (<  108),  inter-
ediate  risk  (between  109  and  140),  and  high  risk  (>  140)
ubgroups  can  be  identiﬁed.  The  probability  of  mortality  at
 months  for  each  of  the  three  subgroups  (low,  intermediate
nd  high  risk)  was  3%,  6%  and  8%  respectively.  The  GRACE
egister,  which  includes  results  for  12,000  patients  in  14
ountries  and  reports  intrahospital  events  at  6  months,  has
hown  that  identiﬁcation  of  unstable  angina  is  associated
ith  a  readmission  rate  of  16%  at  6  months,  revasculariza-
ion  in  8%,  death  in  2.2%  and  myocardial  infarction  in  0.2%
13,14].
The  ‘‘Clinical  Prediction  Rules’’  are  applied  at  the
atient’s  bedside  to  assist  the  clinician  in  decision-making.
hey  are  based  on  prospective  and  retrospective  databases
nd  include  different  variables  from  the  clinical  history,
he  physical  examination  and  basic  laboratory  tests  [15].  A
ecent  review  of  the  literature  [16]  evaluating  the  diagnos-
ic  value  of  the  various  propositions  concluded  that  these
‘clinical  rules’’  are  heterogeneous,  have  major  method-
logical  limitations  and  have  not  been  systematically  and
specially  prospectively  studied  in  routine  clinical  practice.
t  is  therefore  recognized  that  the  information  obtained
rom  the  clinical  investigation,  the  initial  ECG  and  a  single
nzymatic  assay  to  detect  myocardial  ischemia  is  not  sensi-
ive  enough  to  identify  patients  who  can  safely  be  discharged
rom  the  hospital.
Guidelines  for  the  diagnosis  and  stratiﬁcation  of
hese  patients  [10,14]  include  performing  an  ECG  within
0  minutes  after  the  ﬁrst  medical  contact  to  be  interpreted
y  a  doctor  experienced  in  reading  right  chest  and  back
eads  V3R  —  V4R  —  V7-V9,  to  be  repeated  6  and  24  hours  later
nd  before  discharge  from  the  hospital.  Blood  samples  must
e  rapidly  obtained  to  perform  troponin  I and  T  assays.
he  results  should  be  available  within  the  hour  after  the
est,  and  be  repeated  6 and  12  hours  later  if  the  ﬁrst  test  is
egative.  A  GRACE  type  score  should  immediately  be  deter-
ined.
An  echocardiogram  is  recommended  to  exclude  any  pos-
ible  differential  diagnoses  in  patients  without  recurrent
ain,  with  normal  ECGs  and  with  repeatedly  negative  car-
iac  troponin  assays.  A  non-invasive  test  to  provoke  ischemia
s  indicated  before  discharge  (guideline  Ia).  These  guide-
ines  state  that  an  exercise  ECG  stress  test  should  be
erformed  in  patients  with  a  strictly  normal  baseline  ECG
ho  are  capable  of  physical  exercise  (class  IC).  In  the
ther  patients,  a  pharmacological  stress  test  either  in  the
orm  of  cardiac  scintigraphy  (SPECT),  stress  cardioechog-
aphy  or  MRI  should  be  considered  (guideline  1C).  Ideally
 conﬁrmation  test  should  be  available  at  all  times,  to
ontinue  assessment  in  the  observation  unit  to  increase
afety  and  rapid  discharge  following  an  accelerated  pro-
ocol.  An  alternative  strategy  suggests  having  selected  low
isk  patients  (repeatedly  negative  ECG  and  cardiac  biomark-
rs)  perform  a stress  test  as  outpatients.  For  optimal
afety  and  usefulness,  this  outpatient  stress  test  should  be
erformed  within  72  hours  and  preferably  within  24  hours
fter  discharge  with  guaranteed  follow-up  after  the  test
ith  close  communication  between  the  cardiac  observa-
ion  unit,  the  patient  and  the  patient’s  general  practitioner
Fig.  1).
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The role of ‘‘new’’ Troponin (Tn) assays
The  options  proposed  by  existing  guidelines  do  not  take  into
account  ‘‘revolutionary’’  contemporary  ultrasenstive  car-
diac  troponin  T  or  I  assays  that  could  further  accelerate
the  protocols  to  ‘‘rule  out  ACS’’  [17].  Until  recently  most
assays  could  not  reliably  or  reproducibly  detect  low  levels
of  tropinin  (<  0.04  ng/mL).  Several  technological  advances
have  decreased  detection  thresholds  by  10  to  50  times.  The
most  effective  assays  can  now  detect  troponin  in  the  serum
of  healthy  subjects  in  the  99th  percentile  (0.010  ng/mL)  with
a  detection  limit  of  0.0005  ng/mL.  These  assays  provide  pre-
cise  and  early  evaluation  of  variations  in  troponin  during
ACS.  The  negative  predictive  value  (NPV)  of  a  single  test  at
admission  with  these  new  troponin  assays  (with  a  thresh-
old  value  of  14  pg/ml)  has  been  shown  to  be  above  95%
[18—20].  Only  patients  presenting  extremely  early  escape
detection,  but  by  performing  a  second  test  after  three
hours  the  sensitivity  is  nearly  100%  [21—23].  A  test  result
that  is  elevated  and  above  50  pg/ml  for  the  initial  test
and/or  that  doubles  between  the  ﬁrst  and  second  test
three  hours  later,  is  a  sign  of  ACS  [20].  Thus  reducing  the
delay  between  the  two  tests  from  6  to  3  hours  with  ultra-
sensitive  troponin  (Tn  US)  provides  faster  assessment  of
patients.
A  new  decisional  tree  algorithm  is  already  being  used
in  certain  emergency  units.  Low  risk  patients  can  be  dis-
charged  after  3  hours  following  a  single  normal  test  result
(<  14  pg/ml)  if  the  pain  occurred  more  than  6  hours  before
the  consultation,  or  after  a  2nd  normal  test  result  is  obtained
3  hours  after  the  ﬁrst,  if  the  pain  was  less  than  6  hours
before.  Myocardial  ischemia  stress  testing  is  practiced  on
an  outpatient  basis.
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Interpretation  of  the  ultrasensitive  cardiac  troponin  (US
n)  assay  results  should  include  a  clinical  picture  that  sug-
ests  a  diagnosis  of  ACS,  because  although  elevated  US
n  is  extremely  speciﬁc  for  the  presence  of  myocardial
njury,  it  is  not  automatically  suggestive  of  an  ischemic
tiology  [24].  Numerous  other  clinical  situations  besides
CS  could  result  in  initial  and  dynamic  changes  in  US
n,  which  is  generally  modest  and  slow,  even  very  slow.
cute/chronic  renal  failure,  severe  acute/chronic  heart
ailure/insufﬁciency,  sudden  increase  in  blood  pressure,
achy-  or  brady-arrythmia,  a  pulmonary  embolism,  severe
ulmonary  hypertension,  inﬂammatory  disease,  myocardi-
is,  stroke,  intracranial  hemorrhage,  aortic  dissection,  and
cute  diseases,  in  particular  respiratory  failure  or  sepsis  can
e  the  cause.
iagnostic value of coronary CT
ngiography
n  patients  with  a  low  risk  of  ACS  (GRACE  score  <  108),  the
oal  of  an  additional  non-invasive,  morphological  or  func-
ional  imaging  test  is  to  exclude  the  diagnosis  of  coronary
isease:  based  on  a  highly  sensitive  technique  with  the  low-
st  possible  negative  likelihood  ratio  (LR−  is  the  relationship
etween  the  probability  of  having  a  negative  test  result
hen  the  patient  ‘‘is  ill’’  and  the  probability  of  presenting
 negative  test  result  when  the  patient  is  not  ‘‘ill’’).  For
xample  a  LR−  of  0.1  means  that  there  is  10  times  more
hance  of  having  a  negative  test  result  when  the  person
s  not  ill  than  when  s/he  is  ill).  The  diagnostic  value  of  a
egative  result  therefore  increases  as  the  negative  likeli-
ood  ratio  decreases  and  approaches  0  (Fig.  2).  Dobutamine
1108  J.-M.  Pernès  et  al.
Figure 2. Diagnostic value of a technique in relation to the pos-
itive and negative likelihood ratio (LR+ and LR−).  Green area:
very useful technique: LR+ > 10 and LR− < 0.1. Yellow area: useful
technique: LR+ > 5 and LR−  < 0.2. Orange area: moderately useful
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Figure 3. Comparative likelihood ratios and diagnostic values of
coronarography, coronary CT angiography, scintigraphy and stress
echocardiogram in case of suspected ACS. MRI: magnetic resonance
imaging; PET: positron emission tomography or scintigraphy); TTE:
transthoracic echocardiogram; LR: likelihood ratios. The likelihood
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cechnique: LR+ > 2 and LR− < 0.5. Red area: non-useful technique:
V+ < 2 ET RV− > 0.5.
tress  echocardiogram  has  an  excellent  LR−  for  the  absence
f  coronary  artery  stenosis  as  well  as  important  prognostic
alue  for  immediate  and  late  events.  Cardiac  scintigraphy
SPECT)  at  rest,  when  there  is  no  perfusion  anomaly,  is  asso-
iated  with  a  very  low  clinical  risk  so  that  the  patient  can
e  discharged  quickly  to  undergo  a  treadmill  stress  test  as
n  outpatient.
Since  the  development  of  multidetector  CT  (MDCT)
nd  its  use  in  cardiology  (originally  by  retrospective
hen  prospective  ECG-gated),  numerous  publications  have
ocused  on  the  potential  role  of  this  technique  in  the  triage
f  patients  consulting  for  chest  pain  in  emergency  units.
oronary  CT  angiography  is  a  rapid,  non-invasive,  anatomic
echnique  (approximately  15  min  to  perform  a  test,  inter-
retation  after  about  the  same  amount  of  time)  that  is
recise  enough  to  exclude  suspected  heart  disease  with
igniﬁcant  certainty.  In  cases  of  chronic  heart  disease,  all
omparative  studies  and  meta-analyses  have  conﬁrmed  the
xcellent  speciﬁcity  and  LR−  for  the  diagnosis  of  coronary
tenosis  compared  to  coronarography.  Two  meta-analyses
25,26]  have  evaluated  the  diagnostic  value  of  coronary
T  angiography  for  the  speciﬁc  problem  of  ACP.  These  two
eta-analyses  both  included  studies  performed  with  16-,
0-  or  64-slice  CT  devices,  different  methods  of  comparison
coronarography  or  clinical  follow-up)  and  heterogeneity  of
ncluded  patients  in  terms  of  pre-test  risk  of  ACS.  In  the
ost  recent  analysis  by  Athappan  et  al.  [26],  a  systematic
eview  of  the  literature  was  performed  between  1995  and
008  with  16  studies  evaluated,  including  9  that  were  per-
ormed  with  64-slice  coronary  CT  angiography,  and  including
pproximately  1120  patients.  The  diagnostic  value  had  a
ensitivity  of  96%  and  a  speciﬁcity  of  92%,  a  LR+  of  10,  and
 LR−  of  0.09,  all  of  which  show  that  the  diagnostic  value
e
f
patios are in the colored boxes corresponding to their level of use-
ulness (see legend of Fig. 2).
f  this  technique  was  highly  contributive.  These  diagnos-
ic  values  are  not  signiﬁcantly  different  from  those  using
ther  techniques  for  the  functional  exploration  of  myocar-
ial  ischemia.  In  this  situation,  clinical  data  on  efﬁcacy  and
afety  do  not  discriminate  between  the  different  values  of
oronary  CT  angiography,  cardiac  scintigraphy,  echocardiog-
aphy  or  stress  MRI  (Fig.  3).
The  ROMICAT  [27]  study  published  in  2009  provides  a
articularly  clear  picture  of  the  value  of  CT  in  the  triage
f  patients  presenting  in  the  emergency  unit  for  ACP.  The
ncluded  population  (368/1869  or  20%  of  those  consulting
or  ACP)  represents  a ‘‘real  life’’  group  of  low  or  inter-
ediate  risk  patients  with  no  known  coronary/heart  risks
bypass,  stent),  ECG  or  biological  anomalies  or  inclusions
ot  based  on  clinical  scores  that  are  unfamiliar  to  emer-
ency  room  physicians.  Eight  percent  of  the  population  was
ound  to  have  ACS  in  the  immediate  follow-up,  including
5%  with  unstable  angina.  All  patients  received  coronary  CT
ngiography  within  the  hours  following  their  arrival  in  the
ospital,  and  the  results  of  this  test,  which  were  not  pro-
ided  to  the  clinicians,  were  expressed  as  the  presence  or
ot  of  plaque  (yes/no)  and  stenosis  (plaque  >  50%).  Thirty-
our  of  the  368  tests  (9%)  were  inconclusive  (mainly  due  to
igniﬁcant  calciﬁcations)  and  were  included  for  the  global
nalysis  in  the  group  of  patients  considered  to  have  steno-
is  (18%  of  the  total).  None  of  the  patients  without  plaque
50%  of  the  total  population),  presented  with  ACS  (100%  sen-
itivity  and  LR−  of  0!).  On  the  other  hand,  the  speciﬁcity
nd  positive  likelihood  value  were  modest  in  the  presence
f  plaque  as  numerous  patients  presented  with  plaque  but
id  not  develop  ACS.  The  sensitivity  of  the  absence  of  sig-
iﬁcant  stenosis  was  limited  (77%)  with  7  patients  without
dentiﬁed  stenosis  who  developed  ACS,  due  to  the  presence
f  non-obstructive  lesions  or  on  secondary  vessels  detected
n  coronarography;  speciﬁcity  was  ‘‘satisfactory’’  (87%)  as
ost  patients  with  stenosis  developed  ACS.  The  authors
oncluded  that  50%  of  the  patients  who  presented  to  the
mergency  room  could  have  immediately  been  discharged
rom  the  hospital  because  a  normal  coronary  CT  angiogra-
hy  was  never  associated  with  ACS.  Recently  the  same  team
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reported  the  results  of  a  2-year  follow  up  of  the  ROMICAT  1
cohort  for  the  development  of  major  cardiac  events.  They
showed  that  the  rate  of  events  was  0  in  patients  whose
CT  scan  was  normal  2  years  before,  1.2%  in  those  with  a
non-obstructive  lesion  and  8%  in  those  with  stenosis  >  50%
[28].  These  results  show  the  excellent  prognostic  value  of  a
normal  coronary  CT  angiography.
Recently  two  randomized  studies  assessed  the  perti-
nence  of  coronary  CT  angiography  in  the  emergency  room
in  patients  with  suspected  ACS.  In  the  study  by  Litt  et  al.,
[29]  the  primary  judgment  criteria  was  safety  in  relation
to  the  evaluation  of  major  cardiac  events  one  month  later
in  the  CT  group  (908  patients),  compared  to  the  low  risk
group  that  received  traditional  management.  A  total  of
141/908  patients  (16%)  who  were  randomized  into  the  CT
group  did  not  receive  contrast  medium  injection,  mainly
because  of  increased  heart  rate,  a  probably  because  it  was
felt  that  the  quality  of  test  would  have  been  poor.  None
of  the  patients  without  stenosis  >  50%  (83%  of  the  total)
died  or  developed  myocardial  infarction  after  one-month
follow-up.  Fifty  percent  of  the  CT  group  were  discharged
directly  from  the  emergency  room  compared  to  22%  in
the  group  that  was  managed  by  the  traditional  protocol,
resulting  in  a  shorter  overall  hospital  stay  (18/24  hours).
The  goal  of  the  study  by  Hoffman  et  al.  [30]  was  to  evaluate
the  efﬁcacy  of  coronary  CT  angiography  performed  as  early
as  possible  after  ECG  and  cardiac  enzyme  testing  in  low  or
intermediate  risk  patients  with  ACP  (age  between  40  and
75  years  old,  no  history  of  heart  disease,  no  initial  ECG  or
troponin  abnormality)  compared  to  traditional  management
(including  functional  tests).  This  new  scientiﬁc  approach
compared  two  strategies  in  a  randomized  manner  in  which
patient  management  in  both  study  arms  was  performed
according  to  the  rules  of  existing  good  medical  practice  and
not  determined  by  a  strict  protocol.  The  main  difference
with  traditional  randomized  phase  III  studies  was  that  there
was  no  control  of  the  way  patients  were  ‘‘managed’’.  The
main  hypothesis  was  that  performing  coronary  CT  angiogra-
phy  in  the  early  assessment  of  ACP  would  reduce  the  length
of  the  hospital  stay  (primary  criteria).  The  statistical  size
of  the  study  was  determined  with  the  goal  of  identifying
a  reduction  of  8  h  based  on  a  model  of  data  from  ROMICAT
1.  Two  groups  of  500  patients  were  therefore  randomized
including  85,  or  7%  of  the  total  who  presented  with  ACS,
in  the  form  of  a  myocardial  infarction  in  25%  and  unstable
angina  in  75%  (52/85).  Nearly  473/501  patients  in  the  CT
group  (94%)  actually  underwent  exploratory  CT.  The  primary
criteria  was  reached  because  the  length  of  the  hospital
stay  was  reduced  by  7  hours  in  the  CT  group  compared  to
the  standard  management  group,  and  50%  of  the  patients
in  the  CT  group  were  released  after  8  hours,  compared  to
only  10%  in  the  other  cohort.  Among  the  secondary  criteria,
a  diagnosis  was  reached  in  6  hours  compared  to  21  hours
and  the  rate  of  patients  discharged  directly  was  47%  versus
12%  respectively.  There  was  no  statistically  signiﬁcant  dif-
ference  in  the  use  of  additional  resources  or  in  cost  at  one
month,  to  reach  a  diagnosis  or  in  the  occurrence  of  major
cardiac  events.  The  authors  concluded  that  including  a  CT  in
the  triage  strategy  of  patients  presenting  in  the  emergency
room  for  chest  pain  improved  the  efﬁcacy  (the  diagnostic
cost-beneﬁt/proﬁtability)  of  the  decision-making  process.
It  is  important  to  note  that  these  two  studies  as  well  as  all
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reviously  published  studies  were  performed  during  the  day,
o  that  CT  was  performed  during  working  hours  and  never
t  night.  Their  conclusions  are  therefore  limited  to  low  risk
atients  who  could  wait  for  the  CT  unit  to  open  the  next
ay,  or  patients  admitted  during  the  day  when  the  CT  was
ccessible  in  the  hospital  with  no  need  to  be  transferred.
fﬁcacy of coronary CT angiography
ow  that  the  diagnostic  value  of  coronary  CT  angiography
as  been  conﬁrmed,  in  addition  to  the  clinical  assessment,
t  is  necessary  to  obtain  an  economic  assessment  and  take
nto  account  the  organizational  aspects  of  this  approach
n  order  develop  diagnostic  and  follow-up  strategies.  Four
ost-effective  studies  can  be  found  in  the  medico-economic
iterature  [31—34], all  performed  in  American  emergency
ooms,  comparing  management  strategies  including  coro-
ary  CT  angiography  to  management  strategies  including
cintigraphy  (SPECT)  or  stress  echocardiography  in  patients
n  the  emergency  room.  Three  of  these  studies  presented
eparate  results  on  efﬁcacy  (percentage  of  diagnoses,  length
f  hospital  stay)  and  the  costs  of  coronary  CT  angiogra-
hy  versus  stress  echocardiography  or  SPECT  based  on  a
odel  that  calculated  the  incremental  cost-effectiveness
atios  (costs  by  QALY  earned)  of  different  diagnostic  strate-
ies  involving  coronary  CT  angiography,  echocardiography
r  SPECT.  The  results  of  the  studies  agreed.  According
o  the  authors,  in  patients  consulting  in  the  emergency
oom,  64-slice  coronary  CT  angiography  was  as  effective
s  SPECT  (or  stress  echocardiography)  and  less  expensive.
ischarging  patients  based  on  a  negative  coronary  CT  angiog-
aphy  reduces  the  length  of  the  stay  in  the  emergency
nit  compared  to  conventional  management  (with  SPECT  or
tress  echocardiography)  and  reduces  the  cost  of  the  hos-
ital  stay.  Nevertheless,  it  seems  difﬁcult  to  extrapolate
hese  results  to  France.  At  present  there  are  no  French  data
vailable  on  this  topic,  however,  because  of  speciﬁcities  in
rance  in  terms  of  cost  and  access  to  different  imaging  tech-
iques,  we  can  fairly  conﬁdently  estimate  that  in  case  of
uspected  ACS,  a  strategy  including  coronary  CT  angiogra-
hy  as  the  ﬁrst  line  test  would  be  dominant,  because  it  is
ess  expensive  with  a  better  cost-effective  ratio.  Finally,
n  terms  of  safety,  except  in  cases  of  kidney  failure  and
llergic  type  hypersensitivity  to  iodated  contrast  agents,
here  is  no  conﬁrmed  signiﬁcant  risk  associated  with  this
echnique.  Radiation  exposure,  in  particular,  has  been  sig-
iﬁcantly  reduced  by  using  prospective  ECG-gated  CT,  which
s  possible  in  80%  of  the  cases  (possible  by  drug  induced
eduction  of  heart  rate  to  below  65/min)  and  by  iterative
econstruction.  With  these  dose  optimization  protocols,  the
ffective  dose  is  around  2.5  milliSievert  in  the  most  recent
tudies  [35,36].  Moreover,  technical  advances  are  still  being
ade,  in  particular  investigating  the  possibility  of  study-
ng  myocardial  perfusion  at  rest  and  under  pharmacological
tress  to  improve  the  speciﬁcity  of  the  method  [37,38].
European  and  North  American  expert  societies  have
ncluded  an  analysis  of  the  results  of  all  these  clinical  and
edico-economic  studies  in  their  regularly  updated  guide-
ines  on  the  role  of  coronary  CT  angiography  in  the  diagnostic
trategy  of  ACP  and/or  ACS.  Thus,  after  the  original  guide-
ines  in  2006  a  second  version  of  criteria  for  the  use  of  CT  in
1110  J.-M.  Pernès  et  al.
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tigure 4. Proposed decisional tree algorithm including coronary 
he  assessment  of  ACP  was  proposed  in  2010  by  the  Amer-
can  College  of  Cardiology  Foundation  [39]  and  presented
he  following  indications  in  the  following  situations:  the  use
f  CT  was  recommended  for  ACP  in  patients  with  a  low  and
ntermediate  pre-test  risk  of  heart  disease  with  unchanged
CG  and  cardiac  enzymes,  inconclusive  or  non-diagnostic
CG  and  troponin  values.
The  most  recent  document,  dated  2012  (it  is  updated
very  2  years  by  the  same  multidisciplinary  group)  evaluat-
ng  the  different  roles  of  various  imaging  techniques  used  in
he  management  of  ACP  in  subjects  at  low  risk  of  developing
CS,  conﬁrms  the  increasing  importance  and  central  role  of
oronary  CT  angiography  in  this  setting  and  concludes  that
t  must  be  included  in  the  decisional  tree  [40].
Finally  in  the  European  ‘‘guidelines’’  on  the  management
f  NSTEMI,  published  in  2011  [14],  one  grade  IIA  recom-
endation  should  be  mentioned  which  states  that  when  this
echnique  is  available  it  should  be  considered  as  an  alter-
ative  to  coronarography  to  exclude  the  diagnosis  of  ACS
n  patients  with  low  or  intermediate  risk  of  heart  disease
ssociated  with  inconclusive  ECG  and  biochemical  tests.
 new algorithm including coronary CT
ngiography in the management strategy
f ACP
T  has  already  modiﬁed  existing  practices  in  the  manage-
ent  of  acute  chest  pain  suggesting  myocardial  ischemia
nd  associated  with  inconclusive  ECG.  CT  is  indicated  when
ther  obvious  diagnoses  have  been  excluded  and  when  the
S  troponin  assay  is  negative  or  if  the  dynamic  changes  are
odest,  slow  and/or  inconclusive  [14,40—42]. The  latter
ituation  is  increasingly  frequent  (the  number  of  ‘‘positive
ﬁ
r
m
dgiography in case of suspected acute coronary syndrome.
roponins’’  has  been  multiplied  by  4  with  the  US  troponin
est!)  because  the  increased  sensitivity  of  the  US  troponin
ssay  has  been  obtained  at  the  cost  of  a  loss  of  ‘‘coronary’’
peciﬁcity  of  positive  results.
When  the  known  causes  of  elevated  troponin  have  been
liminated  (see  above),  a  coronary  CT  angiography  is  justi-
ed  as  the  ﬁrst  step  in  excluding  ACS  (Fig.  4).  If  t  coronary
T  angiography  is  normal  or  shows  a  non-severe  lesion,  the
iagnosis  of  ACS  can  be  excluded.  In  case  of  discovery  of
evere  stenosis,  coronarography  is  indicated.  In  the  pres-
nce  of  moderate  stenosis  or  an  inconclusive  test,  a  test
f  myocardial  ischemia  (stress  test,  stress  imaging)  should
hen  be  performed  followed  by  a  diagnostic  coronarography
epending  on  the  results.  A  new  protocol  is  needed  with
ptimal  communication  between  the  healthcare  team  and
he  patient  and  that  takes  into  account  cost-effectiveness,
he  real  burden  of  organizational  constraints  as  well  as
ptimization  of  the  triage  process.  Ideally,  coronary  CT
ngiography  should  be  performed  within  3  to  48  hours  after
he  initial  consultation,  thus  avoiding  overbooking  the  Emer-
ency  Unit  or  Cardiology  Intensive  Care  Unit  and  imaging
nits.
The  most  important  factor  for  the  success  of  coronary  CT
ngiography  for  this  application  will  depend  upon  the  capac-
ty  of  emergency  room  specialists  to  properly  select  the
arget  population.  This  population,  we  must  again  empha-
ize,  will  include  patients  with  ACP  in  whom  unstable  angina
ust  be  excluded  after  3  hours  of  observation  as  long  as
o  other  obvious  causes  have  been  discovered  (pleuro-
ericardiac,  musculoskeletal,  digestive,  pulmonary)  during
he  clinical  work-up  that  is  generally  performed  within  the
rst  48  hours.  Between  these  two  limits  (0  and  3  hours)
epeated  ECG  and  2  US  troponin  assays  are  enough  and  the
ost  cost-effective  way  to  conﬁrm  the  presence  of  myocar-
ial  infarction,  STEMI  or  NSTEMI.  No  other  imaging  tests,
CT  a
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[Management  of  acute  chest  pain:  A  major  role  for  coronary  
except  for  a  possible  coronarography,  are  needed  during  this
ﬁrst  period  in  these  patients.
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